Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation

Matrix Biology

Volumn 25, Issue 6, 2006, Pages 332-341

  Droguett, Rebeca ^a   Cabello Verrugio, Claudio ^a   Riquelme, Cecilia ^a   Brandan, Enrique ^a  

^a Center for Advanced Studies in Ecology and Biodiversity   (Chile)

Author keywords

Betaglycan; Biglycan; Decorin; Extracellular matrix; Myogenesis; TGF dependent signaling

Indexed keywords

BETA GLYCAN; BIGLYCAN; DECORIN; LUCIFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOGLYCAN; RECEPTOR SUBUNIT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; RECEPTOR DENSITY; REGULATORY MECHANISM; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; BIGLYCAN; BIOLOGICAL AVAILABILITY; BIOTIN; CELL DIFFERENTIATION; CELL MEMBRANE; DECORIN; ENDOCYTOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; MICE; MUSCLE, SKELETAL; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33747015300     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2006.04.004     Document Type: Article

References (60)

1. Allen R.E., and Boxhorn L.K. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J. Cell. Physiol. 133 (1987) 567-572
2. Ameye L., and Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12 (2002) 107R-116R
3. Ammanamanchi S., and Brattain M.G. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J. Biol. Chem. 279 (2004) 32620-32625
4. Ammanamanchi S., Kim S.J., Sun L.Z., and Brattain M.G. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine. J. Biol. Chem. 273 (1998) 16527-16534
5. Andres J., Stanley K., Cheifetz S., and Massague J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J. Cell. Biol. 109 (1989) 3137-3145
6. Bianco P., Fisher L.W., Young M.F., Termine J.D., and Robey P.G. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38 (1990) 1549-1563
7. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., Miller S.C., and Webster C. Plasticity of the differentiated state. Science 230 (1985) 758-766
8. Bowe M., Mendis D., and Fallon J. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J. Cell Biol. 148 (2000) 801-810
9. Brandan E., Fuentes M.E., and Andrade W. The proteoglycan decorin is synthesized and secreted by differentiated myotubes. Eur. J. Cell Biol. 55 (1991) 209-216
10. Brandan E., Fuentes M.E., and Andrade W. Decorin, a chondroitin/dermatan sulfate proteoglycan is under neural control in rat skeletal muscle. J. Neurosci. Res. 32 (1992) 51-59
11. Brandan, E., Retamal, C., Cabello-Verrugio, C., Marzolo, M.P., submitted for publication. The low density lipoprotein receptor-related protein/ 2 macroglobulin receptor functions as an endocytic receptor for decorin. J. Biol. Chem.
12. Caceres S., Cuellar C., Casar J.C., Garrido J., Schaefer L., Kresse H., and Brandan E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur. J. Cell Biol. 79 (2000) 173-181
13. Casar J.C., McKechnie B.A., Fallon J.R., Young M.F., and Brandan E. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev. Biol. 268 (2004) 358-371
14. Clarke E., Jain N., Brickenden A., Lorimer I., and Sanwal B. Parallel regulation of procollagen I and colligin, a collagen-binding protein and a member of the serine protease inhibitor family. J. Cell. Biol. 121 (1993) 193-199
15. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
16. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., and Miyazono K. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276 (2001) 12477-12480
17. Esparza-Lopez J., Montiel J.L., Vilchis-Landeros M.M., Okadome T., Miyazono K., and Lopez-Casillas F. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J. Biol. Chem. 276 (2001) 14588-14596
18. Fernandez M.S., Dennis J.E., Drushel R.F., Carrino D.A., Kimata K., Yamagata M., and Caplan A.I. The dynamics of compartmentalization of embryonic muscle by extracellular matrix molecules. Dev. Biol. 147 (1991) 46-61
19. Florini J.R., Roberts A.B., Ewton D.Z., Falen S.L., Flanders K.C., and Sporn M.B. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J. Biol. Chem. 261 (1986) 16509-16513
20. Fukushima D., Butzow R., Hildebrand A., and Ruoslahti E. Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. J. Biol. Chem. 268 (1993) 22710-22715
21. Gray P., Bilezikjian L., and Vale W. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol. Cell. Endocrinol. 188 (2002) 254-260
22. Hausser H., Wedekind P., Sperber T., Peters R., Hasilik A., and Kresse H. Isolation and cellular localization of the decorin endocytosis receptor. Eur. J. Cell Biol. 71 (1996) 325-331
23. Hausser H., Schonherr E., Muller M., Liszio C., Bin Z., Fisher L.W., and Kresse H. Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures. Arch. Biochem. Biophys. 349 (1998) 363-370
24. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., and Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302 (1994) 527-534
25. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32 (1997) 141-174
26. Jennische E., Ekberg S., and Matejka G. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am. J. Physiol. 265 (1993) C122-C128
27. Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H., Thomsen G.H., and Wrana J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6 (2000) 1365-1375
28. Koli K.M., and Arteaga C.L. Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation. J. Biol. Chem. 272 (1997) 6423-6427
29. Labarca C., and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102 (1980) 344-352
30. Larrain J., Carey D.J., and Brandan E. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273 (1998) 32288-32296
31. Le Roy C., and Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev., Mol. Cell Biol. 6 (2005) 112-126
32. Li Y., Lu W., Marzolo M.P., and Bu G. Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates. J. Biol. Chem. 276 (2001) 18000-18006
33. Li Y., Foster W., Deasy B.M., Chan Y., Prisk V., Tang Y., Cummins J., and Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 164 (2004) 1007-1019
34. Lo R.S., and Massague J. Ubiquitin-dependent degradation of TGF-beta-activated smad2. Nat. Cell Biol. 1 (1999) 472-478
35. Lopez-Casillas F., Cheifetz S., Doody J., Andres J.L., Lane W.S., and Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67 (1991) 785-795
36. Lopez-Casillas F., Payne H.M., Andres J.L., and Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell. Biol. 124 (1994) 557-568
37. Lopez-Casillas F., Riquelme C., Perez-Kato Y., Ponce-Castaneda M.V., Osses N., Esparza-Lopez J., Gonzalez-Nunez G., Cabello-Verrugio C., Mendoza V., Troncoso V., and Brandan E. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J. Biol. Chem. 278 (2003) 382-390
38. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
39. Massague J., Blain S., and Lo R. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
40. Massague J., Cheifetz S., Endo T., and Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 8206-8210
41. McLennan I.S. Localisation of transforming growth factor beta 1 in developing muscles: implications for connective tissue and fiber type pattern formation. Dev. Dyn. 197 (1993) 281-290
42. McLennan I.S., Koishi K., Zhang M., and Murakami N. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types. Neuroscience 87 (1998) 845-853
43. Melo F., Carey D.J., and Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J. Cell. Biochem. 62 (1996) 227-239
44. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (1997) 631-635
45. Osses N., and Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am. J. Physiol., Cell Physiol. 282 (2002) C383-C394
46. Philip A., Hannah R., and O'Connor-McCourt M.D. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization. Eur. J. Biochem. 261 (1999) 618-628
47. Piek E., Heldin C., and Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13 (1999) 2105-2124
48. Porter J.D., Merriam A.P., Leahy P., Gong B., Feuerman J., Cheng G., and Khanna S. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum. Mol. Genet. 13 (2004) 257-269
49. Riquelme C., Larrain J., Schonherr E., Henriquez J.P., Kresse H., and Brandan E. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 276 (2001) 3589-3596
50. Sakuma K., Watanabe K., Sano M., Kitajima S., Sakamoto K., Uramoto I., and Totsuka T. The adaptive response of transforming growth factor-beta 2 and-beta RII in the overloaded, regenerating and denervated muscles of rats. Acta Neuropathol. (Berl.) 99 (2000) 177-185
51. Sanes J.R. The basement membrane/basal lamina of skeletal muscle. J. Biol. Chem. 278 (2003) 12601-12604
52. Santander, C., and Brandan, E., in press. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal.
53. Tatsumi R., Anderson J., Nevoret C., Halevy O., and Allen R. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 194 (1998) 114-128
54. Ugarte G., and Brandan E. Transforming growth factor β signaling is regulated by electrical activity in skeletal muscle cells: TGF-β type I receptor is transciptionally regulated by myotubes excitability. J. Biol. Chem. (2006) 281
55. Velasco-Loyden G., Arribas J., and Lopez-Casillas F. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J. Biol. Chem. 279 (2004) 7721-7733
56. Wells R.G., Yankelev H., Lin H.Y., and Lodish H.F. Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation. J. Biol. Chem. 272 (1997) 11444-11451
57. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.-.F., and Massague J. TGFbeta signals through a heteromic protein kinase receptor complex. Cell 71 (1992) 1003-1014
58. Yaffe D., and Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270 (1977) 725-727
59. Yamaguchi Y., Mann D., and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346 (1990) 281-284
60. Zhou L., Porter J.D., Cheng G., Gong B., Hatala D.A., Merriam A.P., Zhou X., Rafael J.A., and Kaminski H.J. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul. Disord. 16 (2006) 32-38